With U.S. diagnoses of Parkinson's expected to reach 1.2 million by 2030, research is in full swing, and treatments ...

Parkinson’s disease currently affects nearly one million Americans with no specific known cause and no cure. Treatments have come a long way over the past few decades focusing on managing symptoms and ...

Researchers led by a team from the University of Bath in the UK have achieved just that in a basic worm model of Parkinson's.

Previous applications of TUS were limited, as they were imprecise and too weak to target areas deeper in the brain. Parkinson ...

Weekly intramuscular injections of rotigotine extended-release microspheres are linked to significant symptom improvement in ...

The world's largest-ever clinical trial of treatments to slow or stop the progression of Parkinson's disease has launched, ...

One of the defining features of Parkinson’s is the presence of abnormal protein clumps in the brain known as Lewy bodies.

"Furthermore, patients with RLS who were not treated with dopamine agonists tended to be at increased risk of developing ...

Researchers in the UK have started recruiting patients for a large-scale trial that will test a battery of Parkinson's ...

Emerging evidence indicates that sustainable lifestyle changes—such as increasing physical activity, adopting healthy dietary ...

The world’s largest-ever clinical trial of treatments to slow or stop the progression of Parkinson’s disease has begun across ...

Globally recognized figures Muhammad Ali and Michael J. Fox have long suffered from Parkinson's disease. The disease presents a complex set of motor symptoms, including tremors, rigidity, bradykinesia ...